Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2009
02/19/2009WO2009021908A2 Disposable enzymatic sensor for liquid samples
02/19/2009WO2009021907A1 Disposable sensor for liquid samples
02/19/2009WO2009021600A1 Detection of the human vascular endothelial growth factor
02/19/2009WO2009021551A1 A method for assessing the risk of toxicity in a chemotherapy
02/19/2009WO2009021360A1 Gelsolin binding agent compositions and uses of same
02/19/2009WO2009021322A1 Tumor cell-derived microvesicles
02/19/2009WO2009021293A1 Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
02/19/2009WO2009021269A1 Measurement of sequestered carbon
02/19/2009WO2009006643A8 Measurement of protein using inclusion body dry weight
02/19/2009WO2009005536A3 Methods of capturing bacterial whole cells and methods of analyzing samples for bacteria
02/19/2009WO2009004041A3 Colorimetric assay for the visual detection of primary and secondary amines
02/19/2009WO2008157299A9 Differential expression profiling analysis of cell culture phenotypes and uses thereof
02/19/2009WO2008156629A3 Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells
02/19/2009WO2008156493A3 Integrated quartz biological sensor and method
02/19/2009WO2008155778A3 Assay for detection of transient intracellular ca2+
02/19/2009WO2008154221A3 Modulation of chemosensory receptors and ligands associated therewith
02/19/2009WO2008151200A3 Cancer related isoforms of components of transcription factor complexes as biomarkers and drug targets
02/19/2009WO2008151089A3 Fluorescent phospholipase a2 indicators
02/19/2009WO2008150496A3 Assay for sensitivity to chemotherapeutic agents
02/19/2009WO2008145401A3 Mutated parvovirus structural proteins as vaccines
02/19/2009WO2008140463A3 Biomarker panels for assessing radiation injury and exposure
02/19/2009WO2008127789A3 Molecule attachment to nanoparticles
02/19/2009WO2008127285A3 Target peptides for ovarian cancer immunotherapy
02/19/2009WO2008125667A3 Screening for bone anabolic factors
02/19/2009WO2008106694A3 Systems, methods and compositions for optical stimulation of target cells
02/19/2009WO2008100340A3 Compositions and methods for tissue-based protein truncation test for disease diagnosis
02/19/2009WO2008095462A3 Device and method for detecting the wear of an implant material and correspondingly produced implant
02/19/2009WO2008044038A3 Conjugates for use in analite detection
02/19/2009WO2007124105A4 Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
02/19/2009WO2007104511A8 Cancer vaccine
02/19/2009WO2007084585A3 Non-human primate embryonic stem and germ cells: methods of use and methods of making same
02/19/2009WO2005003311A3 Enzymes for starch processing
02/19/2009US20090049561 Non-human animal exhibiting bone metastasis of tumor cells
02/19/2009US20090048805 Particle Imaging Systems and Methods Using Acoustic Radiation Pressure
02/19/2009US20090048786 Method for Alcohol Content Determination
02/19/2009US20090048785 Methods And Systems For Analyzing Biological Samples
02/19/2009US20090048324 Alternate morpheein forms of allosteric proteins as a target for the development of bioactive molecules
02/19/2009US20090048293 Methods for treating bacillus infection
02/19/2009US20090048288 Method of treating stress-mediated depression
02/19/2009US20090048200 GPR 26 G-Protein Coupled Receptor
02/19/2009US20090048196 Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions
02/19/2009US20090048178 Lps or lipid a binding agent and novel peptide
02/19/2009US20090048176 Antibacterial agent
02/19/2009US20090048173 Use Of Dipyridamole For Treatment Of Resistance To Platelet Inhibitors
02/19/2009US20090048170 Target for anti-angiogenesis therapy
02/19/2009US20090048168 Inhibitors of bcl-2
02/19/2009US20090048164 Therapeutic pro-apoptotic bh3-like molecules and methods for generating and/or selecting the same
02/19/2009US20090048161 Cytokine receptor modulators and uses thereof
02/19/2009US20090048159 Kit for treating a health condition by inducing translocation of a calreticulin protein to a cellular membrane
02/19/2009US20090048150 Materials and Methods for the Detection of Nitrated Fibrinogen
02/19/2009US20090048146 Use of agents that upregulate crystallin expression in the retina and optic nerve head
02/19/2009US20090048121 Screening Method for the Early Diagnosis of Cerebral Vasospasm
02/19/2009US20090048117 Modulation of immune system function by modulation of polypeptide arginine methyltransferases
02/19/2009US20090047753 Scaffold-organized clusters and electronic devices made using such clusters
02/19/2009US20090047746 Analytical Method and Analytical Apparatus
02/19/2009US20090047744 Method for Improving the Characterisation of a Polynucleotide Sequence
02/19/2009US20090047741 Compositions and methods comprising a ligand of chemerin R
02/19/2009US20090047736 Human T1R2 nucleic acid sequences and polypeptides
02/19/2009US20090047696 Detection of infectious prion protein by seeded conversion of recombinant prion protein
02/19/2009US20090047695 Microdevices for high-throughput screening of biomolecules
02/19/2009US20090047694 Clinical Intervention Directed Diagnostic Methods
02/19/2009US20090047692 Optically-detectable enzyme substrates and their method of use
02/19/2009US20090047691 Method for detecting a microorganism in a liquid sample
02/19/2009US20090047690 for identifying and counting lymphocytes in a biological sample such as whole blood, by means of a probe comprising a binding compound specific for a T lymphocyte-specific marker, e.g. a CD2 or CD3, and a binding compound specific for CD45RA; without the need of light scatter-based measurements
02/19/2009US20090047689 Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
02/19/2009US20090047688 Reagents, kits and methods for detecting biological molecules by energy transfer from an activated chemiluminescent substrate to an energy acceptor dye
02/19/2009US20090047687 Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of Preparation
02/19/2009US20090047686 Methods for identifying and producing specific amino acid dependent antibodies and uses thereof
02/19/2009US20090047685 Ultrahighly sensitive determination reagent for c-reactive protein and determination method
02/19/2009US20090047684 Gene and protein expression profiles associated with the therapeutic efficacy of irinotecan
02/19/2009US20090047683 Have negatively charged substituent for fluorescent staining of DNA; used to distinguish DNA present in a sample from RNA
02/19/2009US20090047682 Method of detecting and predicting bronchodilatory response to beta agonist
02/19/2009US20090047676 System and method for obtaining and maintaining high-resistance seals in patch clamp recordings
02/19/2009US20090047668 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
02/19/2009US20090047660 Antibodies for oncogenic strains of HPV and methods of their use
02/19/2009US20090047656 Molecular analysis of primary cells
02/19/2009US20090047654 Polymer affinity matrix, a method for the production and use thereof
02/19/2009US20090047356 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports; antitumor agents; kits
02/19/2009US20090047344 Formulations
02/19/2009US20090047300 Blood-brain barrier epitopes and uses thereof
02/19/2009US20090047290 Monoclonal antibodies against beta3 integrins
02/19/2009US20090047283 Compounds and methods for treatment and diagnosis of chlamydial infection
02/19/2009US20090047282 Prophylactic/Therapeutic Agent for Cancer
02/19/2009US20090047277 Recombinant il-9 antibodies and uses thereof
02/19/2009US20090047274 Diagnostic and therapeutic target cdc2l6 proteins for neurodegenerative diseases
02/19/2009US20090047263 Nuclear reprogramming factor and induced pluripotent stem cells
02/19/2009US20090047246 Novel inhibitors of hepatitis c virus replication
02/19/2009US20090047221 Compounds and compositions useful in the treatment of neoplasia
02/19/2009US20090047217 Polynucleotides Encoding Members of the Human B Lymphocyte Activation Antigen B7 Family and Polypeptides Encoded Thereby
02/19/2009US20090047213 Cytotoxicity mediation of cells evidencing surface expression of CD59
02/19/2009US20090047211 Anti-mesothelin antibodies useful for immunological assays
02/19/2009US20090047181 Determining fluid chemistry of formation fluid by downhole reagent injection spectral analysis
02/19/2009US20090047177 Lactate concentration measurement device
02/19/2009US20090045341 Systems for observing reactions using infrared imaging
02/19/2009US20090045076 System and method for analyte measurement using dose sufficiency electrodes
02/19/2009US20090044643 Method for Determining the Percentage of Allergens Picked Up From a Surface
02/19/2009US20090044605 Device for leaching extraction and assessment
02/19/2009US20090044604 Portable Measuring Facility for Determining A Medically Significant Analyte Concentration
02/19/2009US20090044603 Article, device, and method
02/19/2009US20090044597 Breath sampling device